Tag: VAM 17
Outpatient atherectomy outcomes may be “worse than natural history of disease”
Atherectomy for occlusive disease in the femoral-popliteal and tibial-peroneal segments for claudication in outpatient settings may result in outcomes worse than the natural history...
Bilateral iliac artery aneurysms associated with higher reintervention and spinal cord...
Iliac artery aneurysms—affecting up to one third of patients with complex aortic aneurysms—do not affect all-cause mortality or aneurysm-related mortality in endovascular repair of...
Surgery-first approach for CLI offers faster wound healing rate than endovascular...
A surgical-first strategy appears to be superior to endovascular treatment for critical limb ischaemia (CLI) revascularisation, exhibiting improved wound healing rate and overall healing...
Autologous bone marrow cell injection reduces one-year amputation rate for Rutherford...
Fifty-two-week outcomes of the MOBILE trial indicate a “significant reduction in major amputations” among Rutherford 4 and non-diabetic Rutherford 5 critical limb ischaemia patients...
Excluder Iliac Branch Endoprosthesis device meets mid-term primary endpoints in clinical...
At the 2017 Vascular Annual Meeting (VAM; 30 May–3 June, San Diego, USA), mid-term follow-up data from a pivotal trial (IBE 12-04) of the...
